Antitumor Efficacy of Hypothemycin, A New Ras‐signaling Inhibitor

We have devised a new drug screening assay to discover anti‐cancer drugs which inhibit Ras‐mediated cellular signals, by utilizing a Ras‐responsive element (RRE)‐driven reporter gene system. We found that hypothemycin, an anti‐bacterial, reduces RRE‐dependent transcription. Treatment of tumor cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Hidekazu, Nishida, Kazuyo, Sugita, Kenji, Yoshioka, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1999
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926000/
https://www.ncbi.nlm.nih.gov/pubmed/10595743
http://dx.doi.org/10.1111/j.1349-7006.1999.tb00688.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926000/
https://www.ncbi.nlm.nih.gov/pubmed/10595743
http://dx.doi.org/10.1111/j.1349-7006.1999.tb00688.x

Ejemplares similares